committed to building on her work to help lower prescription drug costs
Lower prescription drug costs for Kansans.
Occurrences
I will keep fighting to lower the cost of prescription drugs and to keep politicians out of our most personal health care decisions.
I worked to cap drug costs, like insulin at thirty five bucks
Rep. Davids introduced legislation to increase transparency in drug pricing and voted to pass the Lower Drug Costs Now Act (H.R. 3), which would drastically reduce costs by allowing Medicare to negotiate for lower drug prices.
I’m dedicated to finding ways to lower the cost of health care and prescription drugs
now, I’m working to extend that cap to everyone.
Transparency in Prescription Drug Advertising Act
Evidence
legacy_unverified · Source version not recorded · locator unknown
Davids says she is dedicated to lowering the cost of health care and prescription drugs, and notes she voted to allow Medicare to negotiate for lower drug prices and to cap insulin at $35 a month for seniors.
legacy_unverified · Source version not recorded · locator unknown
The House roll call for H.R. 5376 shows Sharice Davids (KS) voted yea on passage of the Build Back Better Act.
legacy_unverified · Source version not recorded · locator unknown
The enrolled bill for H.R. 5376 is the Inflation Reduction Act enactment, the law that created Medicare prescription drug price negotiation and other drug-cost reductions.
legacy_unverified · Source version not recorded · locator unknown
Davids introduced H.R. 5894, which would require drug list prices to be included in advertisements and direct HHS to issue drug-price transparency guidance; the bill was referred to committee.
legacy_unverified · Source version not recorded · locator unknown
House Roll Call 420 on H.R. 5376 passed 220-207 on August 12, 2022; Sharice Davids (KS) is listed as voting Yea.
legacy_unverified · Source version not recorded · locator unknown
CMS lists selected drugs and negotiated Maximum Fair Prices, notes the file contains single negotiated prices, and states the first-cycle negotiated prices for 10 Part D drugs go into effect January 1, 2026.
Assessments
Davids materially advanced the promised federal outcome by voting yea on final House passage of H.R. 5376, the Inflation Reduction Act, in August 2022. That enacted law created Medicare drug-price negotiation and other prescription drug affordability provisions, including insulin cost limits for seniors; later CMS implementation confirms the program became operational with negotiated prices. Because the decisive legislative delivery occurred during the 2022 federal office/campaign context while she was serving in the House, this counts as delivered in the same term, with later implementation reinforcing the result rather than changing the timing.
The promise was broad but substantively fulfilled in federal office context because Davids voted for H.R. 5376, the Inflation Reduction Act, which was enacted in 2022 and created major prescription drug cost reductions including Medicare drug price negotiation and insulin cost caps for seniors. Her earlier standalone transparency bill did not advance, but the enacted IRA provisions directly address lowering prescription drug costs and passed while she remained in office, so the outcome warrants full delivery rather than only effort or partial credit.
Davids supported and voted for major federal prescription drug cost measures that became law through the Inflation Reduction Act, including Medicare drug price negotiation and a $35 insulin cap for seniors. Those policies plausibly lowered prescription drug costs for some Kansans, especially Medicare beneficiaries, during the same congressional term. However, the promise was broad and not fully delivered for all Kansans or across prescription drug costs generally, and one separate Davids drug-price transparency bill did not advance beyond committee referral.